Buttonwood Financial Advisors Inc. Decreases Stake in Solventum Co. (NYSE:SOLV)

Buttonwood Financial Advisors Inc. decreased its holdings in shares of Solventum Co. (NYSE:SOLV) by 8.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,504 shares of the company’s stock after selling 336 shares during the quarter. Buttonwood Financial Advisors Inc.’s holdings in Solventum were worth $231,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Blue Trust Inc. raised its holdings in Solventum by 2.1% in the 4th quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock valued at $549,000 after acquiring an additional 161 shares during the last quarter. MML Investors Services LLC grew its position in shares of Solventum by 3.2% in the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock valued at $373,000 after purchasing an additional 168 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Solventum by 4.2% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock valued at $346,000 after purchasing an additional 200 shares during the last quarter. IVC Wealth Advisors LLC lifted its position in Solventum by 5.0% during the third quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company’s stock worth $464,000 after buying an additional 318 shares in the last quarter. Finally, KKM Financial LLC boosted its stake in Solventum by 7.9% during the third quarter. KKM Financial LLC now owns 4,367 shares of the company’s stock worth $304,000 after buying an additional 319 shares during the last quarter.

Solventum Price Performance

Shares of SOLV stock opened at $74.93 on Monday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The firm’s 50 day moving average price is $69.56 and its 200-day moving average price is $66.56. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Solventum (NYSE:SOLV) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.15 EPS for the quarter, missing analysts’ consensus estimates of $1.38 by ($0.23). The business had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.05 billion. On average, research analysts forecast that Solventum Co. will post 6.58 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on SOLV. Piper Sandler raised their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Stifel Nicolaus started coverage on shares of Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price on the stock. Finally, Mizuho began coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target for the company. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $68.29.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.